Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06395870
What this trial is testing

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma-RecurrentB-Cell Non-Hodgkin Lymphoma-Refractory
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Looking for participantsNCT07072169
What this trial is testing

MRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Ruijin Hospital 56
Early research (Phase 1)Study completedNCT01786135
What this trial is testing

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Who this might be right for
Burkitt LymphomaLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+2 more
Seagen Inc. 64
Large-scale testing (Phase 3)Looking for participantsNCT07502118
What this trial is testing

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)Relapsed/Refractory Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma (DLBCL)+2 more
Health Institutes of Turkey 40
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Early research (Phase 1)UnknownNCT04637763
What this trial is testing

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Non Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+4 more
Caribou Biosciences, Inc. 72
Testing effectiveness (Phase 2)Temporarily pausedNCT07098364
What this trial is testing

ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+9 more
Fred Hutchinson Cancer Center 33
Not applicableTemporarily pausedNCT03229876
What this trial is testing

Safety and Efficacy Evaluation of CD19-UCART

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)
Bioray Laboratories 20
Very early researchNot Yet RecruitingNCT06097455
What this trial is testing

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

Who this might be right for
Refractory Non-Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma
Fundacion Clinic per a la Recerca Biomédica 40
Early research (Phase 1)Ended earlyNCT06295549
What this trial is testing

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University 11
Testing effectiveness (Phase 2)Study completedNCT02030834
What this trial is testing

Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas

Who this might be right for
Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas
University of Pennsylvania 63
Early research (Phase 1)UnknownNCT05691153
What this trial is testing

ThisCART19A for B-NHL Relapsed After Auto-CAR T

Who this might be right for
CARB Cell LymphomaRelapsed Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT03056339
What this trial is testing

Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies

Who this might be right for
B-Lymphoid MalignanciesAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT06104592
What this trial is testing

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Who this might be right for
Large B-cell LymphomaRelapsed Non-Hodgkin Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 27
Very early researchLooking for participantsNCT07205315
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia (B-ALL)Chronic Lymphocytic Leukemia (CLL)B-cell Non-Hodgkin's Lymphoma (B-NHL)+1 more
Grit Biotechnology 28
Early research (Phase 1)Looking for participantsNCT06173518
What this trial is testing

CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Who this might be right for
Relapsed or Refractory B Cell Acute Lymphoblastic LeukemiaRelapsed or Refractory B Cell Non-Hodgkin Lymphoma
Autolus Limited 30
Not applicableUnknownNCT06160362
What this trial is testing

The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Henan Cancer Hospital 20
Very early researchLooking for participantsNCT06346912
What this trial is testing

CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

Who this might be right for
Acute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell
Zhejiang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT04844866
What this trial is testing

Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
Miltenyi Biomedicine GmbH 213
Early research (Phase 1)Looking for participantsNCT05365659
What this trial is testing

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non-Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular Lymphoma+2 more
Iksuda Therapeutics Ltd. 140
Next Page